View in EDS HTML Full Text PDF Full Text

Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.

Saved in:
Bibliographic Details
Title: Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
Authors: Yubero, Alfonso1 (AUTHOR) ayuberoe@salud.aragon.es, Barquín, Aranzazu2 (AUTHOR), Estévez, Purificación3 (AUTHOR), Pajares, Bella4 (AUTHOR), Sánchez, Luisa5 (AUTHOR), Reche, Piedad6 (AUTHOR), Alarcón, Jesús7 (AUTHOR), Calzas, Julia8 (AUTHOR), Gaba, Lydia9 (AUTHOR), Fuentes, José10 (AUTHOR), Santaballa, Ana11 (AUTHOR), Salvador, Carmen12 (AUTHOR), Manso, Luis13 (AUTHOR), Herrero, Ana14 (AUTHOR), Taus, Álvaro15 (AUTHOR), Márquez, Raúl16 (AUTHOR), Madani, Julia17 (AUTHOR), Merino, María18 (AUTHOR), Marquina, Gloria19 (AUTHOR), Casado, Victoria20 (AUTHOR)
Source: BMC Cancer. 11/8/2022, Vol. 22 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-022-10191-5